Epicore Bionetworks Inc. V.EBN

Another disappointing quarter

[linpaws]

Any thoughts on the second quarter results? Seems like a new disease has taken further revenues away from Epicore in the Asian market. Would love to see the breakdown of the latin American market and Asian market.

[smallcap87]

The headline numbers are scary but this quarter was actually pretty good. Management is navigating through a ton of headwinds and still eeking out stable revenue. Q2 last year was the second highest on record when shrimp prices were still really high and the $USD was relatively low. To be coming down only 9% is an achievement in my eyes. Latin America was flat year over year (you can see the

[linpaws]

Thanks for the post. Will be interesting to see how they do in the next quarter which is traditionally their strongest. Considering that there two active disease, I can see shrimp prices going up from here due to a shortage in South East Asia.